ClinConnect ClinConnect Logo
Search / Trial NCT07033702

Feasibility and Safety of the Airway Exchange Broncholaryngoscope (AEBLScope)

Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Jun 19, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Tracheostomy Bronchoscope Airway Exchange Feasibility Safety

ClinConnect Summary

This clinical trial is testing a new medical tool called the Airway Exchange Broncholaryngoscope (AEBLScope). This device is designed to help doctors safely and easily change tracheostomy tubes, which are tubes inserted into the windpipe to help people breathe. The study focuses on adults who have had a tracheostomy tube for more than a month and come to the clinic regularly for tube changes. The goal is to see if using this new tool is safe and practical during these routine procedures.

To be part of the study, participants need to be adults who depend on a tracheostomy tube but do not currently need extra oxygen or breathing machines. They must have had at least one previous tube change and be scheduled for a regular tube replacement in a doctor’s office. People with active lung infections, certain lung diseases, very small airway tubes, or who cannot be intubated through the mouth will not be eligible. Participants who join can expect to have their tracheostomy tube changed using this new device while doctors carefully watch for safety and ease of use. This study is not yet recruiting participants, but it aims to improve the experience and safety of tracheostomy care in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥18 years
  • Chronically (\>1 month) tracheostomy-dependent outpatients
  • Currently not requiring ventilatory or supplemental oxygen support
  • Have undergone at least one prior tracheostomy tube exchange
  • Scheduled for routine in-office tracheostomy tube exchange
  • Able to provide informed consent
  • Exclusion Criteria:
  • Active respiratory infection
  • Patients with airway tubes having an inner diameter less than 6.0 mm
  • Patients with preexisting pulmonary conditions, including chronic obstructive pulmonary disease (COPD), restrictive lung disease, untreated pneumonia, or acute respiratory distress syndrome (ARDS)
  • Patients who are tracheostomy-dependent but cannot be orotracheally intubated.
  • Patients unable to provide informed consent and who have no legally authorized representative.

About University Of Southern California

The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.

Locations

Los Angeles, California, United States

Los Angeles, California, United States

Patients applied

0 patients applied

Trial Officials

Karla O'Dell, M.D.

Principal Investigator

Univserity of Southern California

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported